Patent application number | Description | Published |
20120185448 | CONTENT BASED FILE CHUNKING - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for transferring electronic data. In general, one aspect of the subject matter described in this specification can be embodied in methods that include the actions of identifying a data item to be chunked; determining the type of the data item; determining whether the type of the data item is one of a specified one or more types; if it is determined that the type of the data item is not one of the specified one or more types, performing a first chunking of the data item; and if it is determined that the type of the data item is one of the specified one or more types, performing a second chunking of the data item that is based on the particular content portions of the data item. | 07-19-2012 |
20130332916 | SYSTEM AND METHOD FOR UPDATING APPLICATION ARCHIVE FILES - Systems, methods, and non-transitory computer-readable storage media for updating software applications installed on client computing devices, creating a manifest file describing the differences between multiple versions of application archives present in an application distribution system, and coordinating an update process for updating the applications on the client computing devices are disclosed. A scheme of hard-linking to existing files, downloading new files, and erasing unwanted files can be used. | 12-12-2013 |
20150095385 | Content Based File Chunking - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for transferring electronic data. In general, one aspect of the subject matter described in this specification can be embodied in methods that include the actions of identifying a data item to be chunked; determining the type of the data item; determining whether the type of the data item is one of a specified one or more types; if it is determined that the type of the data item is not one of the specified one or more types, performing a first chunking of the data item; and if it is determined that the type of the data item is one of the specified one or more types, performing a second chunking of the data item that is based on the particular content portions of the data item. | 04-02-2015 |
Patent application number | Description | Published |
20120076725 | LUNG CANCER MARKERS, AND USES THEREOF - Methods and compositions are provided for assessing (e.g., diagnosing), treating, and preventing diseases, especially cancer, and particular lung cancer, using lung cancer markers (LCM). Individual LCM and panels comprising multiple LCM are provided for these and other uses. Methods and compositions are also provided for determining or predicting the effectiveness of a treatment or for selecting a treatment using LCM. Methods and compositions are further provided for modulating cell function using LCM. Also provided are compositions that modulate LCM (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate LCM, and agents identified by these screening methods. | 03-29-2012 |
20130177566 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES - Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro. | 07-11-2013 |
20140193419 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES - Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro. | 07-10-2014 |
20140314768 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES - Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro. | 10-23-2014 |
20150037820 | LUNG CANCER MARKERS AND USES THEREOF - Methods and compositions are provided for assessing (e.g., diagnosing), treating, and preventing diseases, especially cancer, and particular lung cancer, using lung cancer markers (LCM). Individual LCM and panels comprising multiple LCM are provided for these and other uses. Methods and compositions are also provided for determining or predicting the effectiveness of a treatment or for selecting a treatment using LCM. Methods and compositions are further provided for modulating cell function using LCM. Also provided are compositions that modulate LCM (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate LCM, and agents identified by these screening methods. | 02-05-2015 |
Patent application number | Description | Published |
20090035299 | Methods and compositions for treating diseases targeting MABA1 - Methods and compositions for diagnosing, detecting and treating a colon disease associated with differential expression of MABA1 in comparison to healthy cells. Also provided are antagonists or agonists of MABA1, and methods for screening agents that modulate the MABA1 level or activity in vivo or in vitro. | 02-05-2009 |
20090082264 | 123 Human Secreted Proteins - The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins. | 03-26-2009 |
20090123461 | HUMAN PODOCALYXIN ALTERNATIVE-SPLICED FORMS AND USES THEREOF - The present invention provides a method for diagnosing and detecting cancer. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in cancer (podocalyxin) and antibodies that bind podocalyxins. The present invention provides that podocalyxins are used as targets for screening agents that modulate podocalyxin activities. Further the present invention provides methods for treating diseases associated with podocalyxin expression. | 05-14-2009 |
20090196873 | Methods and compositions for treating diseases targeting CDCP1 - Methods and compositions for detecting and treating a disease, particularly cancer, associated with differential expression of CDCP1 in disease cells compared to healthy cells. Also provided are antagonists or agonists of CDCP1, and methods for screening agents that modulate the CDCP1 level or activity in vivo or in vitro. | 08-06-2009 |
20100172908 | METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1 - Methods and compositions for diagnosing, detecting and treating a colon disease associated with differential expression of MABA1 in comparison to healthy cells. Also provided are antagonists or agonists of MABA1, and methods for screening agents that modulate the MABA1 level or activity in vivo or in vitro. | 07-08-2010 |
20110250204 | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES - Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods. | 10-13-2011 |